Effects of Empagliflozin + Linagliptin vs Metformin + Insulin Glargine on Renal and Vascular Changes in Type 2 Diabetes
Clinical trial NCT02752113 · COMPLETED
Trial details
- NCT number
- NCT02752113
- Sponsor
- Institut für Pharmakologie und Präventive Medizin
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2018-11-07
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.